Announcements Trials
Browse Landscape

Phase

Phase 1/2 3Phase 2 1Phase 1 1

Status

Completed 3Unknown 1Terminated 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Dermatologic 23Genitourinary 20Other hematologic neoplasm 13Lymphoid 9Sarcoma 8Myeloid 5Gynecologic 5Gastrointestinal 5Breast 4Plasma cell 2CNS 2Tumor-Agnostic 1Other neoplasm 1NET 1Endocrine 1

Conditions

Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Peritoneal Neoplasms 1Papillomavirus Infections 1Ovarian Neoplasms 1Ovarian Cancer Recurrent 1

Interventions

Paclitaxel 575Carboplatin 520Cisplatin 347Bevacizumab 252pembrolizumab 226Gemcitabine 157Topotecan 128liposomal doxorubicin 127Cyclophosphamide 126olaparib 120Taxes 113Radiotherapy 110Docetaxel 94Brachytherapy 89Doxorubicin 84Drug Therapy 80niraparib 75Nivolumab 71Magnetic Resonance Spectroscopy 71Specimen Handling 65fludarabine 56Biopsy 55Hyperthermic Intraperitoneal Chemotherapy 53Filgrastim 52Letrozole 50Oxaliplatin 48durvalumab 47Immunoglobulin G 47atezolizumab 46Platinum 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Interferon alpha-2 × Gynecologic × Clear all
NCT06137950 2025-04-03

Interferon Alpha Therapy for Cervical CINI and HPV Infection

Mongolian National University of Medical Sciences

Phase 1 Completed
60 enrolled
Gynecologic

Uterine Cervical Dysplasia, Papillomavirus Infections

NCT04072263 2021-04-01

OVACURE

Leiden University Medical Center

Phase 1/2 Unknown
12 enrolled
Gynecologic

Ovarian Cancer Recurrent

NCT02151448 2020-07-20

αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies

University of Pittsburgh

Phase 1/2 Completed
64 enrolled 18 charts
Gynecologic

Peritoneal Neoplasms

NCT01639885 2014-01-07

CHIP

Leiden University Medical Center

Phase 1/2 Completed
15 enrolled
Gynecologic

Ovarian Neoplasms

NCT00138151 2013-11-20

Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer

Rutgers, The State University of New Jersey

Phase 2 Terminated
33 enrolled 6 charts
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡